Dr. Smith on Immunotherapy Potential in Multiple Myeloma – OncLive
OncLive |
Dr. Smith on Immunotherapy Potential in Multiple Myeloma
OncLive Although the disease is still considered incurable, immunotherapy is a hopeful way to shift that paradigm and get durable responses—or even cures—in patients. Additionally, he says, monoclonal antibodies such as upfront daratumumab (Darzalex) could … |
